RemSleep Holdings Inc.: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 18, 2023 and accepted by EDGAR at Aug 18, 2023, 06:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $58.7k | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $144.3k | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $50.1k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-01-01 to 2023-06-30 | $123.6k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-01 to 2023-06-30 | $8.6k | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-06-30 | $20.7k | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $48.9k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-06-30 | $75.7k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | −$221.4k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-06-30 | −$442.4k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-01 to 2023-06-30 | $1.8k | us-gaap:InterestExpense |
| Interest expense | 6 months2023-01-01 to 2023-06-30 | $7.1k | us-gaap:InterestExpense |
| Net income | 3 months2023-04-01 to 2023-06-30 | −$223.2k | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | −$449.5k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-01 to 2023-06-30 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-06-30 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 1,461,616,601 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 1,461,616,601 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | −$447.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-06-30 | $128.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-06-30 | $1.1m | us-gaap:Cash |
| Current assets | At period end2023-06-30 | $2.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $2.6m | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $172.0k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $294.1k | us-gaap:Liabilities |
| Current portion of debt | At period end2023-06-30 | $104.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-06-30 | $2.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-23-068698. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.